JP2007520217A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007520217A5 JP2007520217A5 JP2006550364A JP2006550364A JP2007520217A5 JP 2007520217 A5 JP2007520217 A5 JP 2007520217A5 JP 2006550364 A JP2006550364 A JP 2006550364A JP 2006550364 A JP2006550364 A JP 2006550364A JP 2007520217 A5 JP2007520217 A5 JP 2007520217A5
- Authority
- JP
- Japan
- Prior art keywords
- acid sequence
- polypeptide
- seq
- amino acid
- represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001184 polypeptide Polymers 0.000 claims 29
- 102000004196 processed proteins & peptides Human genes 0.000 claims 29
- 108090000765 processed proteins & peptides Proteins 0.000 claims 29
- 125000003275 alpha amino acid group Chemical group 0.000 claims 28
- 150000007523 nucleic acids Chemical group 0.000 claims 21
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 20
- 108091033319 polynucleotide Proteins 0.000 claims 19
- 102000040430 polynucleotide Human genes 0.000 claims 19
- 239000002157 polynucleotide Substances 0.000 claims 19
- 150000001413 amino acids Chemical class 0.000 claims 12
- 238000000034 method Methods 0.000 claims 12
- 206010006187 Breast cancer Diseases 0.000 claims 9
- 208000026310 Breast neoplasm Diseases 0.000 claims 9
- 239000012634 fragment Substances 0.000 claims 4
- 210000001519 tissue Anatomy 0.000 claims 4
- 238000003018 immunoassay Methods 0.000 claims 3
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 108091034117 Oligonucleotide Proteins 0.000 claims 2
- 238000003556 assay Methods 0.000 claims 2
- 210000000481 breast Anatomy 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 210000004027 cell Anatomy 0.000 claims 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims 2
- 230000000295 complement effect Effects 0.000 claims 2
- 238000001514 detection method Methods 0.000 claims 2
- 238000001943 fluorescence-activated cell sorting Methods 0.000 claims 2
- 206010020718 hyperplasia Diseases 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- 238000011065 in-situ storage Methods 0.000 claims 2
- 210000000056 organ Anatomy 0.000 claims 2
- 238000003127 radioimmunoassay Methods 0.000 claims 2
- 108091093088 Amplicon Proteins 0.000 claims 1
- 208000006402 Ductal Carcinoma Diseases 0.000 claims 1
- 238000002965 ELISA Methods 0.000 claims 1
- 208000005726 Inflammatory Breast Neoplasms Diseases 0.000 claims 1
- 206010021980 Inflammatory carcinoma of the breast Diseases 0.000 claims 1
- 208000000265 Lobular Carcinoma Diseases 0.000 claims 1
- 208000025618 Paget disease of nipple Diseases 0.000 claims 1
- 208000024024 Paget disease of the nipple Diseases 0.000 claims 1
- 206010036790 Productive cough Diseases 0.000 claims 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 208000009956 adenocarcinoma Diseases 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 201000003714 breast lobular carcinoma Diseases 0.000 claims 1
- 238000004113 cell culture Methods 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 230000005713 exacerbation Effects 0.000 claims 1
- 239000013604 expression vector Substances 0.000 claims 1
- 210000004251 human milk Anatomy 0.000 claims 1
- 235000020256 human milk Nutrition 0.000 claims 1
- 238000003384 imaging method Methods 0.000 claims 1
- 230000002055 immunohistochemical effect Effects 0.000 claims 1
- 201000004653 inflammatory breast carcinoma Diseases 0.000 claims 1
- 210000000936 intestine Anatomy 0.000 claims 1
- 206010073096 invasive lobular breast carcinoma Diseases 0.000 claims 1
- 210000004880 lymph fluid Anatomy 0.000 claims 1
- 208000027202 mammary Paget disease Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- 201000010879 mucinous adenocarcinoma Diseases 0.000 claims 1
- 230000001537 neural effect Effects 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 210000002381 plasma Anatomy 0.000 claims 1
- 230000000241 respiratory effect Effects 0.000 claims 1
- 210000003296 saliva Anatomy 0.000 claims 1
- 230000028327 secretion Effects 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 210000003802 sputum Anatomy 0.000 claims 1
- 208000024794 sputum Diseases 0.000 claims 1
- 210000002700 urine Anatomy 0.000 claims 1
- 239000013598 vector Substances 0.000 claims 1
- 238000001262 western blot Methods 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53912904P | 2004-01-27 | 2004-01-27 | |
| US62091704P | 2004-10-22 | 2004-10-22 | |
| US62091804P | 2004-10-22 | 2004-10-22 | |
| US62810104P | 2004-11-17 | 2004-11-17 | |
| PCT/IB2005/000433 WO2005072050A2 (en) | 2004-01-27 | 2005-01-27 | Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007520217A JP2007520217A (ja) | 2007-07-26 |
| JP2007520217A5 true JP2007520217A5 (cg-RX-API-DMAC7.html) | 2008-06-19 |
Family
ID=38344787
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006550364A Pending JP2007520217A (ja) | 2004-01-27 | 2005-01-27 | 新規ヌクレオチドおよびアミノ酸配列、ならびにそれを用いた乳癌診断のためのアッセイおよび使用方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2007520217A (cg-RX-API-DMAC7.html) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998007749A1 (en) * | 1996-08-23 | 1998-02-26 | Human Genome Sciences, Inc. | Novel human growth factors |
| JP2003529324A (ja) * | 1999-06-15 | 2003-10-07 | ジェネンテック・インコーポレーテッド | 分泌及び膜貫通ポリペプチドとそれをコードする核酸 |
| EP1259604A1 (en) * | 2000-02-25 | 2002-11-27 | Oxford GlycoSciences (UK) Limited | Bcmp 84, a protein associated to breast cancer |
-
2005
- 2005-01-27 JP JP2006550364A patent/JP2007520217A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI540321B (zh) | 檢測膀胱癌之尿液標記物 | |
| CN109765378B (zh) | 一种新的肝硬化或肝纤维化标志物 | |
| US20080138806A1 (en) | Biomarkers and detection methods for gastric diseases | |
| CN109576368A (zh) | 用于诊断胰腺癌的组合物以及使用其诊断胰腺癌的方法 | |
| ES2300176A1 (es) | Metodo para el diagnostico molecular de cancer de prostata, kit para implementar el metodo. | |
| JP2022058635A (ja) | 大腸癌の検出及び処置方法 | |
| KR20110111491A (ko) | 환자가 병원감염에 걸릴 가능성을 결정하고 패혈 증후군 진행의 예후를 결정하는 방법 | |
| JP2001522238A (ja) | 胃腸管の疾患の検出に有用な試薬および方法 | |
| KR102210333B1 (ko) | 암의 진단용 조성물 | |
| JP2012513584A5 (cg-RX-API-DMAC7.html) | ||
| AU2020200168B2 (en) | Urine markers for detection of bladder cancer | |
| KR101583457B1 (ko) | 다중 당단백질의 발현량 및 당질변이의 측정을 통한 간암의 예측방법 | |
| CN104169435A (zh) | 用于肺癌的体外诊断或预后的方法 | |
| WO2013104103A1 (zh) | 诊断和预示肠癌的标志物 | |
| JP2008507261A5 (cg-RX-API-DMAC7.html) | ||
| TW201317577A (zh) | 預測食道癌存活及癒後狀態之方法及其套組及微陣列晶片 | |
| CN113454242A (zh) | 使用微小rna诊断胃癌的方法 | |
| AU2005320352A2 (en) | Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer | |
| CN112646892B (zh) | 一组乳腺癌早期诊断的piRNA生物标志物及其应用 | |
| JP4576168B2 (ja) | 膀胱尿管逆流症または間質性膀胱炎の検査方法 | |
| JP2007525213A5 (cg-RX-API-DMAC7.html) | ||
| KR101562460B1 (ko) | 요네병 특이적 마커를 포함하는 요네병 진단용 조성물 및 방법 | |
| KR20210109725A (ko) | 암의 진단용 조성물 | |
| WO2007034603A1 (ja) | 悪性脳腫瘍マーカー遺伝子およびその用途 | |
| CN104024434B (zh) | 用于前列腺癌的体外诊断或预后的方法 |